SCHEMBL1760423

SCHEMBL1760423

O=C(O)c1nccnc1N1CCSCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
NEK2 P51955 1/20 0.40
ALOX15 P16050 2/20 0.38
MAPK10 P53779 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 2/20 0.36
ASPH Q12797 1/20 0.36
KDM8 Q8N371 1/20 0.36
POLB P06746 2/20 0.35
MEN1 O00255 1/20 0.34
PKM P14618 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
BLM P54132 1/20 0.34
AGER Q15109 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1760587 0.81 L3MBTL1 (0.39) ALDH1A1ALOX15MAPK10HSD17B10L3MBTL1
SCHEMBL31736542 0.79 HTR2C (0.44) ALDH1A1KDM4E
SCHEMBL30855570 0.79 POLB (0.52) ALDH1A1NEK2L3MBTL1KMT2AKDM4E
SCHEMBL29563688 0.79 CHIA (0.46) ALDH1A1NEK2KMT2AMEN1
SCHEMBL5466087 0.79 POLB (0.52) ALDH1A1NEK2L3MBTL1KMT2AKDM4E
SCHEMBL23536762 0.79 HTR2C (0.44) ALDH1A1KDM4E
SCHEMBL2348152 0.79 ALDH1A1 (0.48) ALDH1A1NEK2ALOX15MAPK10HSD17B10
SCHEMBL874433 0.78 L3MBTL1 (0.43) ALDH1A1HSD17B10L3MBTL1KMT2AKDM4E
SCHEMBL28535164 0.78 L3MBTL1 (0.39) ALDH1A1ALOX15HSD17B10L3MBTL1KMT2A
SCHEMBL2339880 0.77 L3MBTL1 (0.42) ALDH1A1HSD17B10L3MBTL1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057973-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2011-05-19 WO disclosed